جست‌وجوی استاد و پژوهشگر

Cavan S. Reillyمشاهده پروفایل

استاد

• Biostatistics
• Infectious disease epidemiology
• HIV/AIDS
• +۷ مورد دیگر

Cavan S. Reilly is Professor in the Division of Biostatistics & Health Data Science at the University of Minnesota School of Public Health , and concurrently serves as Director of the Coordinating Centers for Biometric Research (CCBR) . His expertise lies in the design, conduct, and analysis of clinical trials and observational studies for infectious diseases, with major programmatic emphases on HIV/AIDS and Ebola virus disease (EVD). Education PhD, Statistics, Columbia University (2000) MS, Statistics, Columbia University (1997) MA, Economics, New School for Social Research (1995) BS, Sociology, University of Minnesota (1993) Research Interests Reilly’s methodological work spans Bayesian modeling , high-dimensional longitudinal analysis , and statistical genomics . Application-wise, he presently directs large-scale trials and cohort studies of Ebola survivors, HIV prevention and treatment strategies, and chronic conditions such as COPD. His lab has produced open-source software for microarray and mass-spectrometry data processing, as well as platforms supporting multi-site clinical data management. Scientific Awards & Recognition Elected Member, Delta Omega Honorary Society in Public Health Teaching & Mentorship At Minnesota, Reilly regularly teaches PubH 8401 Linear Models and has previously offered courses in statistical genetics, Bayesian decision theory, and non-parametric methods. Graduate students working at CCBR routinely receive methodological and domain mentorship under his guidance. Laboratories & Centers He leads the Coordinating Centers for Biometric Research , a major academic contract research organization that provides statistical, data-management, and informatics support to multi-center NIH and international trials in infectious disease and chronic illness.

Maximilian Collatzمشاهده پروفایل

پژوهشگر

• Bioinformatics
• Molecular Diagnostics
• Antibiotic Resistance
• +۶ مورد دیگر

Dr. Maximilian Collatz is a researcher at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in the Research Department of Optical Molecular Diagnostics and System Technology. His work focuses on developing and applying advanced molecular diagnostic techniques for medical applications, particularly in the areas of antibiotic resistance detection and pathogen characterization. Dr. Collatz's research interests span multiple interdisciplinary fields including: Bioinformatics and computational biology for molecular assay design Development of microarray-based diagnostic platforms PCR and isothermal amplification techniques for rapid pathogen detection Characterization of antibiotic-resistant pathogens including MRSA and VRE Evolutionary microbiology and horizontal gene transfer in staphylococci His work bridges the gap between computational approaches and wet-lab molecular biology to create practical diagnostic solutions. Analysis of Dr. Collatz's publication record from 2021-2025 reveals a strong focus on developing bioinformatic tools for molecular diagnostics, particularly for antibiotic-resistant pathogens. His work on AssayBLAST and ConsensusPrime represents significant contributions to in silico primer and probe design, while his research on VRE and MRSA detection demonstrates practical applications of these tools in clinical settings. A notable aspect of his research is the interdisciplinary approach, combining computational biology with microbiology and medical diagnostics. Dr. Collatz has collaborated extensively with researchers including Ehricht, Ralf; Braun, Sascha D.; Monecke, Stefan; and Müller, Elke across multiple publications, indicating strong research networks in the field of molecular diagnostics and antimicrobial resistance.

Shoji Takeuchiمشاهده پروفایل

استاد

• Biohybrid systems
• Micro electro mechanical systems
• Microfluidics
• +۷ مورد دیگر

Shoji Takeuchi is a Professor and Principal Investigator at the Department of Mechano-Informatics, Graduate School of Information Science and Technology, The University of Tokyo. He also serves as Director of the Center for International Research on Integrative Biomedical Systems (CIBiS) at the Institute of Industrial Science (IIS). His interdisciplinary work bridges mechanical engineering, informatics, and biological sciences to create innovative biohybrid systems that integrate biological functionality with micro/nano engineering. Takeuchi received his B.E., M.E., and Dr. Eng. degrees in mechanical engineering from the University of Tokyo in 1995, 1997, and 2000, respectively. His educational background in mechanical engineering provided the foundation for his transition into bio-integrated systems research. His laboratory investigates eight main research areas: Biohybrid Robotics (using skeletal muscle tissue for robot movement), Biohybrid Sensors (ultra-sensitive chemical sensors using cellular receptors), 3D Tissue Construction (including cultured meat development), Artificial Cells/Cell Membrane systems, Implantable Devices, Neural Networks, MEMS/Microfluidic Devices, and Design/Art applications. The research focuses on creating hybrid systems by fusing mechanical components with biomaterials such as biological cells and molecular machines to overcome limitations of purely artificial micromachines. His publications reveal a consistent progression from microfluidic technologies toward increasingly sophisticated integration of biological components with engineered systems. Early work focused on fundamental microfabrication techniques, evolving to complex tissue constructs and functional biohybrid robots. His research spans fundamental biophysics of cell membranes to applied medical devices, demonstrating a clear trajectory toward creating practical biohybrid technologies with real-world applications. MEXT Young Scientists' Prize (2008) JSPS prize (2010) ACS Analytical Chemistry Young Innovator Awards (2015) With over 160 peer-reviewed publications and more than 70 patents filed, Takeuchi leads an active research group mentoring numerous students across multiple disciplines. His laboratory welcomes students from engineering backgrounds to the Department of Mechano-Informatics and students with scientific backgrounds to the Department of Life Sciences. The group has received significant recognition, with Assoc. Prof. Yuya Morimoto winning The Young Scientists' Award of The Commendation for Science and Technology by the Minister of Education in 2021 and Morimoto being awarded Pioneer of New Research Fields Award in 2020. Takeuchi directs the Biohybrid Systems Laboratory at the University of Tokyo, which has gained international recognition with research featured in major media outlets including The Guardian, ABC NEWS, and CNN. The lab's work on cultured meat was highlighted in NIKKEI Asia, and their skin robot research was featured in Matter magazine. The laboratory maintains strong global partnerships and actively participates in international research collaborations, positioning itself at the forefront of biohybrid technology development.

• Gynecologic oncology
• Ovarian cancer
• Breast cancer
• +۵ مورد دیگر

Daniel Gustavo Rosen, M.D. is an Associate Professor in the Department of Pathology & Immunology at Baylor College of Medicine in Houston, Texas. He also holds an appointment in Pathology and Laboratory Medicine . Dr Rosen directs a research program focused on the molecular pathology of gynecologic cancers, with particular emphasis on ovarian and breast carcinoma. Education & Training: M.D., Facultad de Medicina, Universidad de Buenos Aires, Argentina Advanced Training, University of Texas MD Anderson Cancer Center (multiple periods) Advanced Training, Baylor College of Medicine Research Interests: Dr Rosen’s laboratory integrates morphologic pathology with cutting-edge molecular techniques to dissect the biology of ovarian and breast cancers. Major areas include: Functional analysis of imprinted tumor suppressor genes such as ARHI (DIRAS3) Epigenetic regulation via CpG methylation and histone modifications Cell-cycle control molecules (p27 kip1 , Cyclin E) as prognostic biomarkers Calcium signalling pathways mediated by NAADP and cADPR in cancer cells Cancer stem-cell markers (CD133, ALDH1) and their clinical significance Development of genetically defined cell-based and animal models for high-grade serous and endometrioid ovarian carcinoma Publication Themes: Across >40 peer-reviewed papers since 2004, Dr Rosen has consistently explored the molecular underpinnings of tumor progression, chemoresistance, and patient prognosis. His studies traverse basic biochemistry of second-messenger signalling, translational validation of tissue microarray technologies, and large-scale genomic-proteomic profiling of human tumors. Recent work highlights the interplay between oncogenic drivers (RAS, NF-κB, STAT3) and tumor suppressor loss, providing new therapeutic targets and biomarkers. Scientific Awards: No specific awards were listed in the provided sources. Advising & Grants: While the text does not enumerate individual graduate students or specific grant numbers, Dr Rosen’s extensive collaborative publication record with co-authors from multiple institutions indicates active mentorship of post-doctoral fellows, graduate students, and clinical residents in pathology and oncology. His research is supported by intramural and extramural funding typical for an Associate Professor within a comprehensive cancer center environment. Laboratory & Team: Dr Rosen maintains a wet-lab and computational research group at Baylor College of Medicine, located in the BCM-Cullen Building (Room BCMC-286A). The team employs state-of-the-art histopathology, molecular biology, and imaging technologies to pursue translational projects aimed at improving diagnostics and therapy for women with gynecologic malignancies.

• Electrophysiology
• Epithelial Sodium Channels
• Acid Sensing Ion Channels
• +۵ مورد دیگر

Cecilia Canessa is a Professor of Cellular and Molecular Physiology at Yale School of Medicine, where she maintains an active research laboratory focused on ion channel physiology. Her work bridges cellular physiology, molecular biology, and neuroscience through the study of sodium channels in both epithelial and neuronal contexts. Dr. Canessa's primary research interests center on two structurally related but functionally distinct sodium channels: the Epithelial Na + Channel (ENaC) and Acid Sensing Ion Channels (ASIC). Her laboratory examines the structure, function, and regulation of these channels using a diverse array of experimental approaches including electrophysiology (patch-clamp, two-electrode voltage clamp, short-circuit current), molecular cloning from evolutionary distant species, channel modifications, and expression in oocytes, cell lines, and transgenic or knockin mice. Her work on ENaC focuses on mechanisms regulating activity, expression, and trafficking in epithelial cells, particularly the role of serum- and glucocorticoid-induced kinase (Sgk1). Her ASIC research explores biophysical properties and gating mechanisms in central and peripheral nervous system neurons, investigating their roles in nociception, mechanoperception, and synaptic transmission modulation. Analysis of Dr. Canessa's publication record spanning over two decades reveals consistent focus on ion channel structure-function relationships, with particular emphasis on ENaC and ASIC channels. Her research demonstrates strong evolutionary perspective, examining channel properties across species from fish to mammals. The work shows progression from basic channel characterization to more complex regulatory mechanisms involving kinases like SGK1 and their role in physiological processes. Her research maintains strong connections between basic molecular mechanisms and their implications for human physiology and disease. Dr. Canessa's laboratory employs a broad methodological approach combining molecular biology, electrophysiology, and transgenic models to address fundamental questions in cellular physiology. Her work has established important connections between channel structure and function, particularly regarding how specific domains regulate channel properties and how these channels contribute to physiological processes in both epithelial and neuronal tissues.

• Pharmacology
• Clinical Pharmacology
• Toxicology
• +۵ مورد دیگر

Susanne Ammon-Treiber, PD Dr. med., serves as a scientific staff member at the Pharmaceutical Institute of the University of Tübingen within the Faculty of Science, specifically in the Department of Pharmacology, Toxicology and Clinical Pharmacy. Holding dual professional qualifications as both a licensed pharmacist (Apothekerin) and physician (Ärztin) with specialization in Clinical Pharmacology, her work uniquely bridges pharmaceutical sciences and clinical medicine with focus on drug mechanisms, pharmacokinetics, and therapeutic applications. Dr. Ammon-Treiber's academic foundation includes: Pharmacy studies (1983-1988) at University of Tübingen, obtaining Apothekerin licensure in 1988 Human medicine studies (1989-1996) at University of Tübingen Medical doctorate (Dr. med.) from University of Tübingen in 1996 Physician licensure (Approbation) in 1998 Habilitation in Pharmacology at Otto-von-Guericke-Universität Magdeburg (2006) Rehabilitation (Umhabilitation) at Medical Faculty of University of Tübingen (2010) with teaching authorization in Experimental and Clinical Pharmacology Her research program demonstrates sophisticated integration of molecular neuroscience with pharmaceutical applications. Early career work established her expertise in opioid receptor pharmacology, particularly investigating morphine's effects on gene expression, heat shock protein responses, and neuronal adaptation using transgenic mouse models. This foundational neuropharmacological research has evolved toward more applied pharmaceutical technologies, with recent publications focusing on nanoparticle delivery systems for pulmonary administration and cancer therapy. Her work on antisense RNA nanoplexes for lung cancer treatment represents a significant translational advancement from basic mechanism studies to therapeutic applications. Analysis of her publication trajectory from 2002-2012 reveals a strategic progression from fundamental neuropharmacology toward pharmaceutical technology development. While maintaining her expertise in opioid mechanisms and gene expression, she has successfully expanded into drug delivery systems, demonstrating remarkable interdisciplinary versatility. Her research consistently addresses clinically relevant questions while maintaining strong mechanistic foundations. Dr. Ammon-Treiber maintains active membership in professional organizations including the German Society for Pharmaceutical Medicine (DGPharMed) and the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT), reflecting her dual commitment to both pharmaceutical sciences and clinical practice.

John Dowlingمشاهده پروفایل

استاد پژوهشی

• Retina research
• Neuroscience
• Visual system
• +۴ مورد دیگر

John Dowling is a distinguished Research Professor in the Department of Molecular and Cellular Biology at Harvard University's Faculty of Arts and Sciences. With a career spanning over six decades, he has made seminal contributions to our understanding of the vertebrate retina as an accessible part of the central nervous system. Though he has closed his laboratory, he remains actively engaged in research, currently collaborating with Professor Jeff Lichtman and colleagues at the University of Washington to reconstruct the human retinal fovea using connectomic methods. Dowling's research interests focus on retinal mechanisms, with particular emphasis on retinal cells' structure, function, pharmacology, genetics, and synaptic interactions. His work bridges neuroscience and vision science, exploring how understanding retinal mechanisms provides insights into neural mechanisms throughout the brain. He has pioneered the use of zebrafish as a model organism for studying visual system development and function. His publication record demonstrates a consistent trajectory from fundamental retinal physiology to more complex systems neuroscience, with recent work focusing on vision restoration and retinal disease mechanisms. The articles reflect a progression from basic cellular studies to translational research with clinical applications, particularly in age-related macular degeneration and other vision disorders. Dowling has authored numerous influential books including The Retina: An Approachable Part of the Brain (1987, 2012), Neurons and Networks: An Introduction to Neuroscience (1992, 2001), and Understanding the Brain: From Cells to Behavior to Cognition (2018), which have educated generations of neuroscience students. Currently, Dowling is working with Professor Jeff Lichtman's team to reconstruct the human retinal fovea using thousands of tissue sections. This ambitious project aims to understand the structural basis of high-acuity vision and could provide critical insights for treating age-related macular degeneration, the leading cause of legal blindness in the Western world.

• Biomedical Engineering
• Materials Science
• Nanotechnology
• +۳ مورد دیگر

Vincent Pizziconi is an Associate Professor at Arizona State University's School of Biological and Health Systems Engineering. His research focuses on developing bioresponsive and biomimetic materials for medical devices and tissue engineering applications. Ph.D., M.S.E., Arizona State University B.S., University of Massachusetts-Lowell His work spans molecular diagnostics, nanoscale characterization of biological materials, cellular automaton modeling of biocompatibility, and biohybrid sensor development. Key collaborations include Los Alamos National Laboratories, IBM Yorktown, and Harrington Arthritis Research Center. Research trends include: Biohybrid diagnostic devices using mast cells Thermoelectric transducers Hydroxyapatite coatings for implants Nanoscaffold design for tissue repair Optical biomolecular device applications Scientific awards include: Student Stipend Award for Brian Grot (Amer Heart AHA, 1996-1998) Mast Cell-Based Biosensor grant (NSF-ENG, 1994-1998) He has mentored students through honors theses (BME 492/BME 493) and directed biomedical design courses (BME 417/BME 214). His lab has conducted extensive research on cellular automaton algorithms for biocompatibility modeling and molecular recognition at inorganic-organic interfaces. Key research facilities include collaborations with Mayo Clinic Scottsdale for tissue engineering projects (2012-2014) and access to environmental scanning electron microscopy through NSF-funded infrastructure (2002-2004).

Pui-Ying Lamمشاهده پروفایل

استادیار

• Chemo-optogenetic tool development
• In vivo imaging techniques
• Neuroinflammation mechanisms
• +۳ مورد دیگر

Pui-Ying (Penny) Lam, PhD is an Assistant Professor in the Department of Cell Biology, Neurobiology and Anatomy at the Medical College of Wisconsin. Her research focuses on developing novel chemo-optogenetic tools and studying neuroinflammation mechanisms using zebrafish and Danionella cerebrum models. Key projects include TRPswitch technology for vertebrate TRPA1 channels and live imaging of innate immune cell behavior. Lam earned her PhD from the University of Wisconsin-Madison under Dr. Anna Huttenlocher, followed by postdoctoral training at Harvard Medical School and the University of Utah with Dr. Randall Peterson. She has received prestigious awards including an NIH BRAIN Initiative K99/R00 award and an American Heart Association fellowship. Research interests span small molecule screening, optogenetic actuators, and understanding microglia/macrophage dynamics in neuroinflammatory diseases. Her lab combines advanced imaging with molecular and pharmacological approaches to bridge basic science and translational medicine. Labs: Lam Lab (Medical College of Wisconsin) Funding: NIH BRAIN Initiative (R00NS112599) Recruiting: PhD/Master’s trainees and research technologists

• Microfluidics
• Biosensors
• Nanoplasmonics
• +۱ مورد دیگر

Dr. Alba Calatayud-Sanchez is a Research Fellow at ICFO's Neurophotonics and Mechanical Systems Biology group. Her research focuses on developing advanced microfluidic and nanoplasmonic tools for biomedical applications, including single-cell analysis, biosensing, and drug toxicity testing. She holds a PhD in Microfluidics and Biosensors from the University of the Basque Country. Research interests span microengineering approaches for biological applications, including micro-contact printing, fiber-optic nanosensors, and cell adhesion monitoring technologies. Her work integrates principles from photonics, nanotechnology, and cell biology to create novel diagnostic platforms. Recent publications demonstrate innovation in microfluidic biosensor design, nanoplasmonic detection methods, and single-cell analysis techniques, with applications in drug screening, biomolecular detection, and cellular monitoring. Collaborates within interdisciplinary teams at ICFO to develop optical technologies for biological systems analysis.

• Biomedical Engineering
• Pharmacology
• Polymer Science
• +۳ مورد دیگر

Rose Jamaledin is a Researcher in the Department of Life Sciences at the University of Bath. Her work focuses on biomedical innovations, particularly in microneedle patch technology, polymer-based drug delivery systems, and wound healing solutions. She has contributed to advancements in antimicrobial materials, biodegradable polymers, and biomaterial design. Her research interests span wound healing mechanisms, polymer science applications, and the development of smart drug delivery systems. Key areas include optimizing microneedle arrays for transdermal delivery, enhancing material biocompatibility, and creating stimuli-responsive systems for controlled drug release. Rose's recent publications highlight breakthroughs in PVA-based wound patches, PLGA vaccine carriers, and bioinspired microneedle designs. These studies emphasize translational research bridging lab-to-bedside applications. Her work addresses challenges in skin penetration mechanics, long-term vaccine efficacy, and antimicrobial resistance. While no academic awards or grants are explicitly listed, her extensive publication record reflects sustained engagement with cutting-edge biomedical engineering challenges. Collaborations span multiple countries, indicating international recognition of her research contributions.

• Genomics
• Molecular Pathology
• Clinical Bioinformatics
• +۳ مورد دیگر

Ryan Jason Schmidt, MD, PhD, is an Assistant Professor of Clinical Pathology at the University of Southern California. His research focuses on genomic diagnostics, molecular pathology, and clinical bioinformatics, with a particular emphasis on pediatric genetics and oncology. He has contributed to developing standards for clinical bioinformatics practice and improving diagnostic workflows through genomic analysis. His work spans genomic characterization of pediatric cancers, gene fusion detection in tumors, and the integration of epigenetic markers in tumor diagnosis. He has co-authored guidelines on variant classification, risk allele reporting, and next-generation sequencing validation in collaboration with professional societies. Dr. Schmidt's recent studies highlight advancements in optical genome mapping, copy number variant analysis, and transcriptome sequencing applications in clinical settings. His publications emphasize precision medicine applications and ethical considerations in gene editing for pathologists. He holds a leadership role in the Association for Molecular Pathology's Clinical Bioinformatician Body of Knowledge project and has developed educational initiatives for clinical pathology residents in reference laboratory settings.

Eneko Larrañetaمشاهده پروفایل

استاد

• Drug Delivery Systems
• Biomaterials
• Polymer Chemistry
• +۵ مورد دیگر

Eneko Larrañeta is a Professor at Queen's University Belfast within the School of Pharmacy Material and Advanced Technologies for Healthcare. His expertise spans drug delivery systems, biomaterials, and implantable devices for sustained drug release, leveraging 3D printing and additive manufacturing technologies. He holds a BSc and PhD from the University of Navarra, with postdoctoral research in nanotechnology for drug delivery. Research focuses on advanced implantable systems addressing chronic conditions, emphasizing tailored drug release profiles and biocompatible materials. Over 100 peer-reviewed publications and multiple book contributions highlight his contributions to pharmaceutical science. Notable achievements include being named a Clarivate Highly Cited Researcher (2023) and recognition as a top 2% global scientist in his field (Stanford University analysis). Teaching responsibilities include Applied Pharmaceutical Analysis, Mass Spectrometry, Nuclear Magnetic Resonance, and Enzyme Kinetics. He actively collaborates with pharmaceutical and biotechnology firms, securing grants from major organizations. Key projects involve 3D-printed antimicrobial materials, microneedle arrays for HIV treatment, and ocular drug delivery systems. Scientific Awards: Clarivate Highly Cited Researcher (2023) Academy of Medical Sciences Springboard Award (2020) Fellow of the UK Higher Education Academy (2018) Grants & Projects: 3D-printed antimicrobial materials for safer medical devices (2018–2023) Nanoengineered microneedles for HIV medicines (2019–2023) Ocular research via integrated training (ongoing) Labs & Teams: Collaborates with interdisciplinary teams in drug delivery, biomaterials, and 3D printing, fostering industry partnerships.

Nancy Allbrittonمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Technology
• Single-Cell Analysis
• +۵ مورد دیگر

Nancy Allbritton is the Frank & Julie Jungers Dean of the University of Washington (UW) College of Engineering and a Professor of Bioengineering. She holds a PhD in Medical Physics from MIT, an MD from Johns Hopkins University, and a B.S. in Physics from Louisiana State University. Her research focuses on biomedical microdevices, organ-on-a-chip technologies, and single-cell analytical techniques, with applications in oncology, gastrointestinal diseases, and regenerative medicine. She has pioneered technologies leading to 15 commercial products and co-founded multiple companies, including Protein Simple and Altis Biosystems. Dr. Allbritton’s work bridges engineering, chemistry, and medicine. Her lab develops microfluidic platforms, cell sorting technologies, and in vitro tissue models. Notable achievements include the creation of the first functional intestine-on-a-chip system and patented single-cell enzyme assay methods. She serves on editorial and advisory boards for journals and institutions globally, including the Annual Review of Analytical Chemistry and the National Academy of Engineering. Her awards include election to the National Academy of Engineering (2024), AAAS Fellowship (2015), and the Ralph Adams Award (2020). She actively mentors researchers through her lab and industry collaborations, driving translational research from bench to clinic.

• Translational Molecular Pathology
• Hematopathology
• Leukemia and Lymphoma Diagnostics
• +۳ مورد دیگر

Richard Byers is an Associate Professor (Reader) in Pathology at the University of Manchester and a Consultant Haematopathologist at Manchester Royal Infirmary. He holds an honorary clinical chair with MAHSC and is affiliated with the Division of Cancer Sciences. His expertise spans molecular pathology, leukemia/lymphoma diagnostics, and translational research applying prognostic gene signatures. He developed quantum-dot (qdot) based multiplex ISH during a sabbatical at the Broad Institute of MIT and Harvard (2003-2004). Education: BSc in Anatomy, MSc in Cell and Structural Biology, PhD in Molecular Biology (bone biology) Roles: Chair of the Molecular Pathology Group (Pathological Society of GB&I), co-organizer of Molecular Pathology Summer School Research focuses on diagnostic applications of microarray-derived gene signatures, including real-time PCR and qdot ISH for acute leukemia, lymphoma, and pancreatic/prostate cancers. Techniques emphasize clinical applicability across tumor types. Key collaborations: Broad Institute, MIT Publications: Over 118 outputs including high-impact journals like British Journal of Cancer and Cancer Immunology Immunotherapy Professional service includes journal reviewing ( Journal of Pathology , British Journal of Haematology ) and roles in clinical pharmacology groups. His work contributes to UN SDG 3 (Good Health and Well-being).